← Back
$AKRO All transactions

Akero Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$40K

Shares

2,000

Price

$20

Filed

Jun 20

Insider

Name

Lamy Patrick

Title

Senior VP, Commercial Strategy

CIK

0001961273

Roles

Officer

Transaction Details

Transaction Date

2025-06-16

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

34,573

Footnotes

The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 6, 2025, previously adopted by the Reporting Person. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $53.52 to $54.37, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $54.70 to $55.57, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. | This option shall vest and become exercisable in 48 equal monthly installments, commencing on December 8, 2023

Filing Info

Accession No.

0000950170-25-088206

Form Type

4

Issuer CIK

0001744659

Lamy Patrick's History

Date Ticker Type Value
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-07-01 AKRO $106K
2025-06-30 AKRO A $5K

Other Insiders at AKRO (90d)

No other insider activity at this issuer in the last 90 days.